Cardiovascular-related proteins identified in human plasma by the HUPO plasma proteome project pilot phase

Proteomics

Volumn 5, Issue 13, 2005, Pages 3520-3530

  Berhane, Beniam T ^a,b   Zong, Chenggong ^a   Liem, David A ^a   Huang, Aaron ^a   Le, Steven ^a   Edmondson, Ricky D ^c   Jones, Richard C ^c   Qiao, Xin ^a   Whitelegge, Julian P ^b   Ping, Peipei ^a   Vondriska, Thomas M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Atherosclerosis; Biomaker; Biosignature; Blood; Ischemic heart disease; Myocardial infraction

Indexed keywords

PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; BODY FLUID; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL GROWTH; CYTOSKELETON; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; MASS SPECTROMETRY; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SIGNAL TRANSDUCTION;

ARTERIOSCLEROSIS; BLOOD PROTEINS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CELL PROLIFERATION; CYTOSKELETON; DATABASES, PROTEIN; GENETIC MARKERS; HUMANS; INFLAMMATION; MASS SPECTROMETRY; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PEPTIDES; PILOT PROJECTS; PROTEOME; PROTEOMICS; TRANSCRIPTION, GENETIC;

EID: 23944449609     PISSN: 16159853     EISSN: None     Source Type: Journal    
DOI: 10.1002/pmic.200401308     Document Type: Article

References (28)

1. Granger, C. B., Van Eyk, J. E., Mockrin, S. C., Anderson, N. L., Circulation 2004, 109, 1697-703.
2. Anderson, N. L., Polanski, M., Pieper, R., Gatlin, T., Tirumalai, R. S., Conrads, T. P., Veenstra, T. D et al., Mol. Cell. Proteomics 2004, 3, 311-326.
3. Petricoin, E. F., Liotta, L. A., Curr. Opin. Biotechnol. 2004, 15, 24-30.
4. Omenn, G. S., States, J. D., Adamski, M., Blackwell, T. W., Menon, R., Hermjakob, H., Apweiler, R. et al., Proteomics 2005, 5, this issue.
5. American Heart Association. Heart Disease and Stroke Statistics: 2004 Update, American Heart Association, Dallas, Texas, USA.
6. World Health Organization. The World Health Report, 2004. www.who.int.
7. Libby, P., Nature 2002, 420, 868-874.
8. Morrow, D. A., Braunwald, E., Circulation 2003, 108, 250-252.
9. Yeh, E. T. H., Circulation 2004, 109, 1111-1114.
10. Baker, H. M., Anderson, B. F., Baker, E. N., Proc. Natl. Acad. Sci. USA 2003, 100, 3579-3583.
11. Franke, F. E., Pauls, K., Metzger, R., Danilov, S. M., APMIS 2003, 111, 234-244.
12. Deitcher, S. R., Jaff, M. R., Rev. Cardiovasc. Med. 2002, 3, S25-S33.
13. Olson, E. N., Nat. Med. 2004, 10, 467-474.
14. He, W., Miao, F. J., Lin, D. C., Schwandner, R. T., Wang, Z., Gao, J., Chen, J. L et al., Nature 2004, 429, 188-193.
15. Salvesen, G. S., Abrams, J. M., Oncogene 2004, 23, 2774-2784.
16. Barnes, P. J., Adcock, I. M., Ann. Intern. Med. 2003, 139, 359-370.
17. Nadal-Ginard, B., Kajstura, J., Leri, A., Anversa, P., Circ. Res. 2003, 92, 139-150.
18. Laron, Z., J. Clin. Pathol: Med. Pathol. 2001, 54, 311-316.
19. Bolli, R., Dawn, B., Xuan, Y. T., Trends Cardiovasc. Med. 2003, 13, 72-79.
20. Rockman, H. A., Koch, W. J., Lefkowitz, R. J., Nature 2002, 415, 206-212.
21. Zagon, I. S., Verderame, M. F., McLaughlin, P. J., Brain Res. Rev. 2002, 38, 351-376.
22. Gross, G. J., J. Mol. Cell Cardiol. 2003, 35, 709-718.
23. Freitas, E. M., Phan, T. C., Herbison, C. E., Christiansen, F. T, Taylor, R. R., Van Bockxmeer, F. M., J. Cardiovasc. Risk 2002, 9, 59-65.
24. Dayer, J.-M., Best Prac. Res. Clin. Rheumatol. 2004, 18, 31-45.
25. Bradham, W. S., Bozkurt, B., Gunasinghe, H., Mann, D., Spinale, F. G., Cardiovasc. Res. 2002, 53, 822-830.
26. Wehrens, X. H., Marks, A. R., Nat. Rev. Drug Discov. 2004, 3, 565-573.
27. Romi, F., Gilhus, N. E., Varhaug, J. E., Myking, A., Skei, G. O., Aarli, J. A., Ann. NY Acad. Sci. 2003, 998, 481-490.
28. Niessen, P., Clement, S., Fontao, L., Chaponnier, C., Teunissen, B., Rensen, S., van Eys, G. et al., Exp. Cell Res. 2004, 292, 170-178.